Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study

Massimo Federico; Stefano Luminari; Cinzia Pellegrini; Francesco Merli; Emanuela Anna Pesce; Stephane Chauvie; Letizia Gandolfi; Isabella Capodanno; Massimiliano Salati; Lisa Argnani; Pier Luigi Zinzani

doi:10.3324/haematol.2015.138388

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study

Massimo Federico, Stefano Luminari, Cinzia Pellegrini, Francesco Merli, Emanuela Anna Pesce, Stephane Chauvie, Letizia Gandolfi, Isabella Capodanno, Massimiliano Salati, Lisa Argnani, Pier Luigi Zinzani

Arcispedale Santa Maria Nuova

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	e139-e141
Number of pages	3
Journal	Haematologica
Volume	101
Issue number	4
DOIs	https://doi.org/10.3324/haematol.2015.138388
Publication status	Published - Mar 31 2016

Keywords

ABVD
Brentuximab vedotin
Early
Hodgkin lymphoma
Intermediate
Radiotherapy
Toxicity

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2015.138388

Cite this

Federico, M., Luminari, S., Pellegrini, C., Merli, F., Pesce, E. A., Chauvie, S., Gandolfi, L., Capodanno, I., Salati, M., Argnani, L., & Zinzani, P. L. (2016). Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study. Haematologica, 101(4), e139-e141. https://doi.org/10.3324/haematol.2015.138388

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma : Final results of a pilot phase II study. / Federico, Massimo; Luminari, Stefano; Pellegrini, Cinzia; Merli, Francesco; Pesce, Emanuela Anna; Chauvie, Stephane; Gandolfi, Letizia; Capodanno, Isabella; Salati, Massimiliano; Argnani, Lisa; Zinzani, Pier Luigi.

In: Haematologica, Vol. 101, No. 4, 31.03.2016, p. e139-e141.

Research output: Contribution to journal › Article

Federico, M, Luminari, S, Pellegrini, C, Merli, F, Pesce, EA, Chauvie, S, Gandolfi, L, Capodanno, I, Salati, M, Argnani, L & Zinzani, PL 2016, 'Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study', Haematologica, vol. 101, no. 4, pp. e139-e141. https://doi.org/10.3324/haematol.2015.138388

Federico, Massimo ; Luminari, Stefano ; Pellegrini, Cinzia ; Merli, Francesco ; Pesce, Emanuela Anna ; Chauvie, Stephane ; Gandolfi, Letizia ; Capodanno, Isabella ; Salati, Massimiliano ; Argnani, Lisa ; Zinzani, Pier Luigi. / Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma : Final results of a pilot phase II study. In: Haematologica. 2016 ; Vol. 101, No. 4. pp. e139-e141.

@article{ee52b63123f6417f912039516159d293,

title = "Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study",

keywords = "ABVD, Brentuximab vedotin, Early, Hodgkin lymphoma, Intermediate, Radiotherapy, Toxicity",

author = "Massimo Federico and Stefano Luminari and Cinzia Pellegrini and Francesco Merli and Pesce, {Emanuela Anna} and Stephane Chauvie and Letizia Gandolfi and Isabella Capodanno and Massimiliano Salati and Lisa Argnani and Zinzani, {Pier Luigi}",

year = "2016",

month = mar,

day = "31",

doi = "10.3324/haematol.2015.138388",

language = "English",

volume = "101",

pages = "e139--e141",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "4",

}

TY - JOUR

T1 - Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma

T2 - Final results of a pilot phase II study

AU - Federico, Massimo

AU - Luminari, Stefano

AU - Pellegrini, Cinzia

AU - Merli, Francesco

AU - Pesce, Emanuela Anna

AU - Chauvie, Stephane

AU - Gandolfi, Letizia

AU - Capodanno, Isabella

AU - Salati, Massimiliano

AU - Argnani, Lisa

AU - Zinzani, Pier Luigi

PY - 2016/3/31

Y1 - 2016/3/31

KW - ABVD

KW - Brentuximab vedotin

KW - Early

KW - Hodgkin lymphoma

KW - Intermediate

KW - Radiotherapy

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=84962343919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962343919&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.138388

DO - 10.3324/haematol.2015.138388

M3 - Article

AN - SCOPUS:84962343919

VL - 101

SP - e139-e141

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -